Source: The Street NEW YORK -- Specialty pharmaceutical company Actavis (ACT) reported fourth-quarter and full-year earnings results Wednesday that beat analysts' estimates. And the company, which late last year inked a deal to acquire Allergan (AGN), maker of anti-wrinkle treatment Botox, for $66 billion, said it will adopt Allergan as…...